MedTrace Logo

Impact of Adding Integrated Neuromuscular Inhibition Technique to Cervical Stabilization Exercise in Chronic Mechanical Neck Pain

NCT07699458 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2026-07-13

No results posted yet for this study

Summary

the goal of this clinical trial is to study the Impact of adding integrated neuromuscular inhibition technique to cervical stabilization exercise in chronic mechanical neck pain

Conditions

  • Mechanical Neck Pain

Interventions

DEVICE

Cervical stabilization exercise and Integrated Neuromuscular Inhibition

cervical stablization exercise starting with cervical isometric exercises performed in the supine position. The head will be supported on a pillow with a towel roll placed under the cervical spine to ensure proper alignment. Additional cervical isometric exercises will be conducted in the seated position by applying manual resistance at the forehead to perform cervical flexion, extension, rotation, and side-bending movements. The Integrated Neuromuscular Inhibition will be applied to the upper trapezius muscle to deactivate myofascial trigger points and reduce muscle tension. The technique will consist of three sequential components: intermittent ischemic compression, strain counterstain, and muscle energy technique

DEVICE

Integrated neuromuscular inhibition technique

Integrated Neuromuscular Inhibition will be applied to the upper trapezius muscle to deactivate myofascial trigger points and reduce muscle tension. The technique will consist of three sequential components: intermittent ischemic compression, strain counterstain, and muscle energy technique

OTHER

Conventional Treatment group

Participants in this group will receive conventional physical therapy only in the form of superficial heat using hot pack for 10 minutes, stretching exercise, isometric neck exercise and posture advice for 3 sessions/week over 4 weeks' periods.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hytham mohammed elhafez, PhD · Cairo University

  • rania reda mohammed, PhD · Cairo univeristy

  • heba ahmed elgyar, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-25
Primary Completion
2026-12-10
Completion
2027-01-25

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07699458 on ClinicalTrials.gov